Synapse

← Elliott M. Antman

Papers by Elliott M. Antman

Page 5 · newest first

  1. Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary SyndromesJAMA · 2004
  2. Pharmacoinvasive TherapyCirculation · 2004
  3. Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial InfarctionCirculation · 2004
  4. Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial InfarctionCirculation · 2004
  5. Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation · 2004
  6. Implications of Upstream Glycoprotein IIb/IIIa Inhibition and Coronary Artery Stenting in the Invasive Management of Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation · 2004
  7. Isolated Right Ventricular InfarctionNew England Journal of Medicine · 2003
  8. ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive SummaryCirculation · 2003
  9. Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non‐ST‐segment elevation myocardial infarctionBritish Journal of Clinical Pharmacology · 2003
  10. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary ArticleCirculation · 2003
  11. American College of Cardiology/American Heart Association Clinical Practice Guidelines: Part IICirculation · 2003
  12. Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?JAMA · 2003
  13. Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary SyndromesCirculation · 2003
  14. Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary InterventionJAMA · 2003
  15. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary ArticleCirculation · 2002
  16. Decision Making with Cardiac Troponin TestsNew England Journal of Medicine · 2002
  17. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-IIEuropean Heart Journal · 2002
  18. Managing ST elevation myocardial infarctionEuropean Heart Journal Supplements · 2002
  19. Managing ST elevation myocardial infarctionEuropean Heart Journal Supplements · 2002
  20. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive SummaryAnesthesia & Analgesia · 2002
  21. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary SyndromesCirculation · 2002
  22. Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial InfarctionCirculation · 2002
  23. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)Circulation · 2002
  24. Underutilization of Evidence-Based Medications in Acute ST Elevation Myocardial InfarctionCritical Pathways in Cardiology A Journal of Evidence-Based Medicine · 2002
  25. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)Circulation · 2001
  26. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and ElectrophysiologyCirculation · 2001
  27. Low-Molecular-Weight Heparins in the Treatment of Acute Coronary SyndromesArchives of Internal Medicine · 2001
  28. Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial InfarctionCirculation · 2001
  29. The Search for Replacements for Unfractionated HeparinCirculation · 2001
  30. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at PresentationCirculation · 2000
  31. ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and RecommendationsCirculation · 2000
  32. High Levels of Platelet Inhibition With Abciximab Despite Heightened Platelet Activation and Aggregation During Thrombolysis for Acute Myocardial InfarctionCirculation · 2000
  33. Clinical Efficacy of Three Assays for Cardiac Troponin I for Risk Stratification in Acute Coronary Syndromes: A Thrombolysis In Myocardial Infarction (TIMI) 11B SubstudyClinical Chemistry · 2000
  34. The Length of the Hospital Stay after Myocardial InfarctionNew England Journal of Medicine · 2000
  35. Abciximab Improves Both Epicardial Flow and Myocardial Reperfusion in ST-Elevation Myocardial InfarctionCirculation · 2000
  36. Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation · 1999
  37. Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation · 1999
  38. 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and RecommendationsCirculation · 1999
  39. Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation · 1999
  40. The role of cardiac Troponin‐I (cTnI) in risk stratification of patients with unstable coronary artery diseaseClinical Cardiology · 1999
  41. Low-Molecular-Weight HeparinsCirculation · 1998
  42. Prospective Temporal Analysis of the Onset of Preinfarction Angina Versus OutcomeCirculation · 1998
  43. Equivalence TrialsNew England Journal of Medicine · 1997
  44. Antiarrhythmic Drug Therapy in the Management of Atrial FibrillationJournal of Cardiovascular Electrophysiology · 1997
  45. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive SummaryCirculation · 1996
  46. The role of magnesium therapy in acute myocardial infarctionClinical Cardiology · 1996
  47. Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 1996
  48. Hirudin in Acute Myocardial InfarctionCirculation · 1996
  49. Atrial Fibrillation and Flutter: Maintaining Stability of Sinus Rhythm Versus Ventricular Rate ControlJournal of Cardiovascular Electrophysiology · 1995
  50. Knowledge and Practices of Generalist and Specialist Physicians Regarding Drug Therapy for Acute Myocardial InfarctionNew England Journal of Medicine · 1994